Determining Patterns In Study Experiences of Neuroblastoma Patients

Part of paid clinical trials in San Francisco, California.

Sponsor
Power Life Sciences Inc.
Study ID
NCT05918432
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

Historically, participation in clinical research is highly skewed towards particular demographic groups of people. This study will invite several participants to gather a wide range of information on clinical trial experiences for neuroblastoma patients. The aim of the study is to identify the factors that limit the ability of a person to enroll in, as well as complete a clinical trial for treatment of neuroblastoma. The data collected from this study will help improve future outcomes for all neuroblastoma patients as well as those in under-represented demographic groups.

Key Dates

Start date
Jul 31, 2024
Status verified
Jun 2023
Primary completion
Jul 31, 2025
Completion
Jul 31, 2026

Study Design

Enrollment
500 participants (estimated)

Primary Outcome Measure

Number of patients who decide to enroll in a neuroblastoma clinical trial [ Time Frame: 3 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Power Life SciencesSan FranciscoCalifornia94107-

Find similar trials in San Francisco, CA

By condition
Neuroblastoma
By specialty
OncologyPediatric oncology
By research site
Power Life Sciences· San Francisco, CA

Related Studies